International Journal of Hematology

, Volume 73, Issue 1, pp 115–118 | Cite as

Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia

  • Kiyomi Ishiga
  • Toshio Kawatani
  • Takeaki Suou
  • Fumihito Tajima
  • Hiromi Omura
  • Youko Idobe
  • Hironaka Kawasaki
Case Report

Abstract

We report a case of a 41-year-old man with acute myelogenous leukemia who developed fulminant hepatitis from reactivation of trace hepatitis B virus (HBV) 2 months after complete remission.Although he became positive for HB surface antigen at the onset of fulminant hepatitis, he had been negative for HBV serum markers, and only HBV DNA was detected by polymerase chain reaction (PCR) amplification on admission. The original stocks of serum samples from all blood donors were tested again for HBV DNA by PCR, and all samples were negative. This case demonstrates that testing for HBV DNA by PCR is necessary before chemotherapy, because silent HBV carriers are rare and fulminant hepatitis may be induced by chemotherapy in patients with hematologic malignancies.

Key words

Hepatitis B virus Acute myelogenous leukemia Fulminant hepatitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lok ASF, Liang RHS, Chiu EKW, Wong K-L, Chan T-K, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy.Gastroenterology. 1991;100:182–188.PubMedGoogle Scholar
  2. 2.
    Lau GKK, Liang R, Chiu EKW, Lee CK, Lam SK. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study.Bone Marrow Transplant. 1997;19:795–799.CrossRefPubMedGoogle Scholar
  3. 3.
    Nakamura Y, Motokura T, Fujita A, Yamashita T, Ogata E. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies: Survey in Japan, 1987–1991.Cancer. 1996;78:2210–2215.CrossRefPubMedGoogle Scholar
  4. 4.
    Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.Nat Med. 1996;2:1104–1108.CrossRefPubMedGoogle Scholar
  5. 5.
    Altfeld M, Rockstroh JK, Addo M, et al. Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal.J Hepatol. 1998;29:306–309.CrossRefPubMedGoogle Scholar
  6. 6.
    Grotz W, Rasenack J, Benzing T, et al. Occurrence and management of hepatitis B virus reactivation following kidney transplantation.Clin Nephrol. 1998;49:385–388.PubMedGoogle Scholar
  7. 7.
    Ohno R, Kobayashi T, Morishima Y, et al. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).Leukemia. 1992;6:(Suppl 2)92–95.PubMedGoogle Scholar
  8. 8.
    Abe A, Inoue K, Tanaka T, et al. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR.J Clin Microbiol. 1999;37:2899–2903.PubMedGoogle Scholar
  9. 9.
    Dusheiko G, Song E, Bowyer S, et al. Natural history of hepatitis B virus infection in renal transplant recipients—a fifteen-year follow-up.Hepatology. 1983;3:330–336.CrossRefPubMedGoogle Scholar
  10. 10.
    Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.N Engl J Med. 1999;341:22–26.CrossRefPubMedGoogle Scholar
  11. 11.
    Cacciola I, Pollicino T, Squadrito G, et al. Quantification of intra-hepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection.Hepatology. 2000;31:507–512.CrossRefPubMedGoogle Scholar
  12. 12.
    Senecal D, Pichon E, Dubois F, Delain M, Linassier C, Colombat P. Acute hepatitis B after autologous stem cell transplantation in a man previously infected by hepatitis B virus.Bone Marrow Transplant. 1999;24:1243–1244.CrossRefPubMedGoogle Scholar
  13. 13.
    Locasciulli A, Bacigalupo A, Van Lint MT, et al. Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases.Bone Marrow Transplant. 1990;6:25–29.PubMedGoogle Scholar
  14. 14.
    Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus.Lancet. 1996;347:92–93.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2001

Authors and Affiliations

  • Kiyomi Ishiga
    • 1
  • Toshio Kawatani
    • 1
  • Takeaki Suou
    • 1
  • Fumihito Tajima
    • 1
  • Hiromi Omura
    • 1
  • Youko Idobe
    • 1
  • Hironaka Kawasaki
    • 1
  1. 1.Second Department of Internal Medicine, Faculty of MedicineTottori UniversityYonagoJapan

Personalised recommendations